Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05724368

Efficacy of Calprotectin as A Marker For the Pathogenicity of Blastocystis Infection

Conditions: Blastocystis Infections

Sex: All
Ages: 6 Years – 70 Years
Healthy volunteers: 1
Enrollment: 150
Sponsor: Sohag University

Summary

Blastocystis which is commonly found in the gastro-intestinal tract, has been recognized as a non-pathogenic organism for a few decades. It has a variable distribution. A high prevalence has been reported in developing countries (22.1-100%).In developed countries, the prevalence ranges from 0.5% to 23.1%. The high prevalence noted in developing countries is related to poor hygiene and lack of safe water and food .

Eligibility Criteria

Inclusion Criteria:Patients from outpatient clinics, Sohag hospitals.Exclusion Criteria:Patients taking antibiotics within the previous four weeks, and anti-parasitic drugs within the previous two weeks.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05724368). StuddyBuddy aggregates publicly available trial information.